⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRPT News
Sarepta Therapeutics,, Inc. Common Stock
FSHD Industry Collaborative Expands with Four Biopharma Sponsors and Reports Rapid Advances Across Multiple Muscular Dystrophy Research Programs
prnewswire.com
SRPT
ROCK
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Secretome Therapeutics Expands Rare Disease Leadership Team
businesswire.com
SRPT
RPRX
PFE
BIIB
GILD
AMGN
ATRA
The Speak Foundation Announces 2026 LGMD Scientific Summit
prnewswire.com
BBIO
SRPT
ASMB
EDIT
Form 8-K
sec.gov
SRPT
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
businesswire.com
SRPT
Cell and Gene Therapy Global Market Opportunities And Strategies To 2035 Published — Analyzes Hospitals, Cancer Care Centers and Other End Users
globenewswire.com
GILD
NVS
BMY
JNJ
SRPT
VRTX
AMGN
Duchenne Muscular Dystrophy Treatment Market Report (2025-2034) Published, Segments Intravenous, Subcutaneous, and Oral Routes Across Three Pharmacy Channels
globenewswire.com
SRPT
PFE
BIIB
REGN
GILD
JNJ
ABBV
NVS
SNY
CAPR
SLDB
WVE
EDIT
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Sarepta Therapeutics, Inc. (SRPT)
globenewswire.com
SRPT
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SRPT